Immunosuppressive Therapy for Patients With Myelodysplastic Syndrome: A Prospective Randomized Multicenter Phase III Trial Comparing Antithymocyte Globulin Plus Cyclosporine With Best Supportive Care-SAKK 33/99

J.R. Passweg; A.A.N. Giagounidis; M. Simcock; C. Aul; C. Dobbelstein; M. Stadler; G.J. Ossenkoppele; W.K. Hofmann; K. Schilling; A. Tichelli; A. Ganser

doi:https://doi.org/10.1200/JCO.2010.31.2686

Immunosuppressive Therapy for Patients With Myelodysplastic Syndrome: A Prospective Randomized Multicenter Phase III Trial Comparing Antithymocyte Globulin Plus Cyclosporine With Best Supportive Care-SAKK 33/99

J.R. Passweg, A.A.N. Giagounidis, M. Simcock, C. Aul, C. Dobbelstein, M. Stadler, G.J. Ossenkoppele, W.K. Hofmann, K. Schilling, A. Tichelli, A. Ganser

Hematology (VUmc)

Research output: Contribution to journal › Article › Academic › peer-review

165 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	303-309
Journal	Journal of clinical oncology
Volume	29
Issue number	3
DOIs	https://doi.org/10.1200/JCO.2010.31.2686
Publication status	Published - 2011

Access to Document

https://doi.org/10.1200/JCO.2010.31.2686

Cite this

Passweg, J. R., Giagounidis, A. A. N., Simcock, M., Aul, C., Dobbelstein, C., Stadler, M., Ossenkoppele, G. J., Hofmann, W. K., Schilling, K., Tichelli, A., & Ganser, A. (2011). Immunosuppressive Therapy for Patients With Myelodysplastic Syndrome: A Prospective Randomized Multicenter Phase III Trial Comparing Antithymocyte Globulin Plus Cyclosporine With Best Supportive Care-SAKK 33/99. Journal of clinical oncology, 29(3), 303-309. https://doi.org/10.1200/JCO.2010.31.2686

@article{541e4f1e8a9746d1be977a758556dff8,

title = "Immunosuppressive Therapy for Patients With Myelodysplastic Syndrome: A Prospective Randomized Multicenter Phase III Trial Comparing Antithymocyte Globulin Plus Cyclosporine With Best Supportive Care-SAKK 33/99",

author = "J.R. Passweg and A.A.N. Giagounidis and M. Simcock and C. Aul and C. Dobbelstein and M. Stadler and G.J. Ossenkoppele and W.K. Hofmann and K. Schilling and A. Tichelli and A. Ganser",

year = "2011",

doi = "https://doi.org/10.1200/JCO.2010.31.2686",

language = "Undefined/Unknown",

volume = "29",

pages = "303--309",

journal = "Journal of clinical oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "3",

}

Passweg, JR, Giagounidis, AAN, Simcock, M, Aul, C, Dobbelstein, C, Stadler, M, Ossenkoppele, GJ, Hofmann, WK, Schilling, K, Tichelli, A & Ganser, A 2011, 'Immunosuppressive Therapy for Patients With Myelodysplastic Syndrome: A Prospective Randomized Multicenter Phase III Trial Comparing Antithymocyte Globulin Plus Cyclosporine With Best Supportive Care-SAKK 33/99', Journal of clinical oncology, vol. 29, no. 3, pp. 303-309. https://doi.org/10.1200/JCO.2010.31.2686

Immunosuppressive Therapy for Patients With Myelodysplastic Syndrome: A Prospective Randomized Multicenter Phase III Trial Comparing Antithymocyte Globulin Plus Cyclosporine With Best Supportive Care-SAKK 33/99. / Passweg, J.R.; Giagounidis, A.A.N.; Simcock, M. et al.
In: Journal of clinical oncology, Vol. 29, No. 3, 2011, p. 303-309.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Immunosuppressive Therapy for Patients With Myelodysplastic Syndrome: A Prospective Randomized Multicenter Phase III Trial Comparing Antithymocyte Globulin Plus Cyclosporine With Best Supportive Care-SAKK 33/99

AU - Passweg, J.R.

AU - Giagounidis, A.A.N.

AU - Simcock, M.

AU - Aul, C.

AU - Dobbelstein, C.

AU - Stadler, M.

AU - Ossenkoppele, G.J.

AU - Hofmann, W.K.

AU - Schilling, K.

AU - Tichelli, A.

AU - Ganser, A.

PY - 2011

Y1 - 2011

U2 - https://doi.org/10.1200/JCO.2010.31.2686

DO - https://doi.org/10.1200/JCO.2010.31.2686

M3 - Article

C2 - 21149672

SN - 0732-183X

VL - 29

SP - 303

EP - 309

JO - Journal of clinical oncology

JF - Journal of clinical oncology

IS - 3

ER -

Passweg JR, Giagounidis AAN, Simcock M, Aul C, Dobbelstein C, Stadler M et al. Immunosuppressive Therapy for Patients With Myelodysplastic Syndrome: A Prospective Randomized Multicenter Phase III Trial Comparing Antithymocyte Globulin Plus Cyclosporine With Best Supportive Care-SAKK 33/99. Journal of clinical oncology. 2011;29(3):303-309. doi: https://doi.org/10.1200/JCO.2010.31.2686